Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
358
-
Total shares
-
88.8M
-
Shares change
-
-4.39M
-
Total reported value, excl. options
-
$12.7B
-
Value change
-
-$611M
-
Put/Call ratio
-
1.04
-
Number of buys
-
185
-
Number of sells
-
-143
-
Price
-
$143.04
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2018
382 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q3 2018.
DEXCOM INC - Common Stock (DXCM) has 358 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.8M shares
of 392M outstanding shares and own 22.66% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (7.94M shares), FMR LLC (6.37M shares), MORGAN STANLEY (5.48M shares), BAILLIE GIFFORD & CO (5.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.5M shares), BlackRock Inc. (4.16M shares), WELLINGTON MANAGEMENT GROUP LLP (3.42M shares), JPMORGAN CHASE & CO (3.41M shares), Capital International Investors (3.33M shares), and BROWN ADVISORY INC (3.03M shares).
This table shows the top 358 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.